Wherley Joel L's Form 4 filing
Chemed Corp (CHE) · filed Aug 6, 2026
- Accession no.
- 0001193125-26-337649
- Filed
- Aug 6, 2026, 2:17 PM ET
- Trade date
- Aug 5, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wherley Joel LCIK 0002083070 | Officer (CEO - Vitas Healthcare) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 5, 2026 | Capital Stock | MOption exerciseAcquired | +2,599 | $445.35 | +$1,157,464.65 | 3,451 | Direct | |
| Aug 5, 2026 | Capital Stock | FTax withholdingDisposed | −2,270 | $542.62 | −$1,231,747.4 | 1,181 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 5, 2026 | Capital Stock | MOption exerciseDisposed | −2,599 | $445.35 | −$1,157,464.65 | 30,220 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.